View Single Post
Old 11-25-2012, 07:31 PM   #7
phil
Senior Member
 
Join Date: Nov 2010
Posts: 393
Re: after seeing the NBCC call to arms 4 Genentech--I decided2 post this negative

When original herc. was appr., was it given to all her2 + ? or just for Stage IV ? did they run trials for early stage ? and thus make those w/ strong over expr of Her2 wait yrs to get it ?
I think not, and, if not , then whats changed since 1996 ? Is the appr process now slower ?? Wheres the progress ? it seems insane to delay T DM-1 longer for early stage ? it has an effectiveness at late stages of 40-50 % , ( " the best survival stats ever seen so far " in her2 cancer , and that includes original herc ) and thus will have even greater results at early stage.
Again I say NBCC has been NO HELP w/ T DM-1, completely in This FDAs pocket.
phil is offline   Reply With Quote